|
Program
Description | Learning Objectives
| Agenda | Faculty
| CE | Registration
home
> Learning Objectives
At
the conclusion of this program, attendees should be able to:
- Compare
and contrast the different kinds of monoclonal antibodies in terms
of nomenclature, method of generation, and safety profile.
- Describe
current standards of care for the adjuvant and metastatic treatment
of colorectal cancer.
- Discuss
the results of recent clinical trials using monoclonal antibodies
in combination with the traditional chemotherapeutic agents for
the management of colorectal cancer.
- Describe
current clinical trials and their potential impact on the management
of colorectal cancer.
|
